Publi­ka­tio­nen

Alte­red tha­l­a­mic glu­co­se meta­bo­lism in cere­bel­lar pro­jec­tions in Parkinson’s disease

Autoren: Pel­zer EA, Nahhas Y, Titt­ge­mey­er M, Tim­mer­mann L, Eggers C.
Basal Gan­glia (14) 1–7

The Meta­bo­lic Pat­tern of Idio­pa­thic REM Sleep Beha­vi­or Dis­or­der Reflects Ear­ly-Sta­ge Par­kin­son Disease.

Autoren: Meles SK, Ren­ken RJ, Jan­zen A, Vadasz D, Paga­ni M, Arnal­di D, Mor­bel­li S, Nobi­li F, May­er G, Leen­ders KL, Oer­tel WH; REM­PET Stu­dy Group.
J Nucl Med 59(9):1437–1444

Pati­ent-cen­te­red inte­gra­ted health­ca­re impro­ves qua­li­ty of life in Parkinson’s dise­a­se pati­ents: a ran­do­mi­zed con­trol­led trial.

Autoren: Eggers C, Dano R, Schill J, Fink GR, Hell­mich M, Tim­mer­mann L; CPN stu­dy group.
J Neu­rol 265(4): 764–773

Limi­ta­ti­ons of a Short Demo­gra­phic Ques­ti­onn­aire for Bedsi­de Esti­ma­ti­on of Pati­ents’ Glo­bal Cogni­ti­ve Func­tio­n­ing in Epi­le­psy Patients.

Autoren: Gor­ny I1, Krau­se K1, Albert A1, Schnei­der S1, Möl­ler L1, Haber­mehl L1, Strzel­c­zyk A1,2, Rosenow F1,2, Hermsen A1,2, Kna­ke S1, Menz­ler K1.
Front Neu­rol 9:85

Bri­var­ace­tam in the Tre­at­ment of Pati­ents with Epi­le­psy-First Cli­ni­cal Experiences.

Autoren: Zahnert F1, Krau­se K1, Immisch I1, Haber­mehl L1, Gor­ny I1, Chmi­e­lew­s­ka I1, Möl­ler L1, Weyand AM1, Mross PM1, Wag­ner J1, Menz­ler K1, Kna­ke S1.
Front Neu­rol 9:38

Access to End-of Life Parkinson’s Dise­a­se Pati­ents Through Pati­ent-Cen­te­red Inte­gra­ted Healthcare.

Autoren: Eggers C, Dano R, Schill J, Fink GR, Tim­mer­mann L, Voltz R, Gol­la H, Lorenzl
Front Neu­rol 9:627

Direct elec­tro­phy­sio­lo­gi­cal evi­dence for pre­fron­tal con­trol of hip­po­cam­pal pro­ces­sing during vol­un­ta­ry forgetting.

Autoren: Oehrn CR, Fell J, Bau­mann C, Ros­burg T, Ludo­wig E, Kess­ler H, Hanslmayr S, Axmacher
Curr Biol CB 28 (18), 3016–3022

Low-Fre­quen­cy and Rare-Coding Varia­ti­on Con­tri­bu­tes to Mul­ti­ple Scle­ro­sis Risk.

Autoren: Mitro­vič M, Patsopou­los NA, Bee­cham AH, Dan­kow­ski T, Goris A, Dubo­is B, D’hooghe MB, Lem­mens R, Van Dam­me P, Søn­der­gaard HB, Sel­leb­je­rg F, Soren­sen PS, Ullum H, Thør­ner LW, Wer­ge T, Saa­re­la J, Cour­­nu-Rebeix I, Damo­t­te V, Fon­tai­ne B, Guil­­lot-Noel L, Lathrop M, Vuku­sik S, Gour­raud PA, And­lau­er TFM, Pongratz V, Buck D, Gas­pe­ri C, Bayas A, Heesen C, Kümp­fel T, Lin­ker R, Paul F, Stan­ge M, Tacken­berg B, Bergh FT, Warn­ke C, Wiendl H, Wil­de­mann B, Zettl U, Zie­mann U, Tuma­ni H, Gold R, Grum­mel V, Hem­mer B, Knier B, Lill CM, Lues­si F, Dar­dio­tis E, Agli­ar­di C, Bariz­zo­ne N, Mascia E, Ber­nar­di­nel­li L, Comi G, Cusi D, Espo­si­to F, Fer­rè L, Comi C, Galim­ber­ti D, Leo­ne MA, Soro­si­na M, Mesche­ria­ko­va J, Hint­zen R, van Dui­jn C, Teunis­sen CCE, Bos SD, Myhr KM, Celi­us EG, Lie BA, Spurk­land A, Coma­bel­la M, Mon­tal­ban X, Alfreds­son L, Stridh P, Hil­lert J, Jago­dic M, Piehl F, Jelčić I, Mar­tin R, Sospe­dra M, Ban M, Haw­kins C, Hysi P, Kal­ra S, Kar­pe F, Kha­da­ke J, Lach­an­ce G, Nevil­le M, San­ta­ni­ello A, Cail­lier SJ, Cala­bre­si P, Cree BAC, Cross A, Davis MF, Hai­nes JL, de Bak­ker PIW, Del­ga­do S, Dem­be­le M, Edwards K, Fitz­ge­rald KC, Hako­nar­son H, Koni­da­ri I, Lathi E, Man­ri­que CP, Peri­­cak-Van­ce MA, Pic­cio L, Schae­fer C, McCa­be C, Wei­ner H, Gold­stein J, Ols­son T, Had­ji­geor­giou G, Tay­lor B, Tajo­o­ri L, Charles­worth J, Booth DR, Har­bo HF, Ivin­son AJ, Hau­ser SL, Compston A, Ste­wart G, Zipp F, Bar­cel­los LF, Bar­anzini SE, Mar­­ti­­nel­­li-Bone­­schi F, D’Alfonso S, Zieg­ler A, Otu­rai A, McCau­ley JL, Saw­cer SJ, Oksen­berg JR, De Jager PL, Kockum I, Haf­ler DA, Cots­apas C.
Cell 175(6): 1679–1687

Pati­en­ten­per­spek­ti­ve auf die Ver­sor­gungs­si­tua­ti­on im Krank­heits­bild Mor­bus Par­kin­son in Deutsch­land – eine Querschnittserhebung.

Autoren: Bin­der S, Grop­pa S, Woital­la D, Mül­ler T, Wel­lach I, Klu­cken J, Eggers C, Liersch S, Ame­lung VE Akt Neu­rol 2018; 45(10): 703–713